Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2005
06/28/2005US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity
06/28/2005US6911463 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity
06/28/2005US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse
06/28/2005US6911457 Diabetes imaging probes
06/28/2005US6911453 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
06/28/2005US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
06/28/2005US6911424 2′-fluoronucleosides
06/28/2005US6911416 Substituted N-benzoyl-n′(tetrazolylphenyl)-ureas and their use as pest control agents
06/28/2005CA2259977C Taxane derivatives and drugs containing the same
06/23/2005WO2005056549A1 Water-soluble etoposide analogs and methods of use thereof
06/23/2005WO2005056548A1 Enantiomerically pure epoxiconazole and its use as crop protection agent
06/23/2005WO2005056544A1 2- ( (2, 3-dihydroxypropyl) aminomethyl) chromane derivatives for use as beta-3 adrenoreceptor agonists in the treatment of urological and inflammatory disorders
06/23/2005WO2005056543A2 Process for use in the preparation of oxiranes from alkenes, and catalysts for use therein
06/23/2005WO2005056535A1 1,2,3-triazole amide derivatives as inhibitors of cytokine production
06/23/2005WO2005056533A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
06/23/2005WO2005056532A1 Indazole derivatives which interact with the g-protein coupled receptor family
06/23/2005WO2005056015A1 Substituted piperazines
06/23/2005WO2005056004A1 N-alkyl pyrroles as hmg-coa reductase inhibitors
06/23/2005WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005WO2005055940A2 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005WO2005055715A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
06/23/2005WO2005040156A8 Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes
06/23/2005WO2005037272A8 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors
06/23/2005WO2005034870A3 Amide compounds and ion channel ligands and uses thereof
06/23/2005WO2005033105A3 Vanilloid receptor ligands and their use in treatments
06/23/2005WO2004052366A9 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
06/23/2005WO2004041258A8 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses
06/23/2005US20050137399 A lithium-free reaction to produce a substituted/unsubstituted 4-amino-3-benzimidazol-2-yl-quinolin-2-one compound by reacting a 2-aminobenzonitrile with a 2-alkyloxycarbonylmethyl-benzimidazole in a solvent in the presence of a sodium or potassium salt of a base; excellent yields
06/23/2005US20050137395 E.g., 6-[(7-iodoquinolin-4-yl)oxy]-N,2-dimethyl-1-benzofuran-3-carboxamide; antiproliferative agent for hyperproliferative disorders being either cancerous or noncancerous; vasculogenesis or angiogenesis inhibitors; adminstered with hypotensive agent, antitumor agents, mitotic inhibitors and others
06/23/2005US20050137243 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
06/23/2005US20050137234 Histone deacetylase inhibitors
06/23/2005US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide
06/23/2005US20050137228 Benzyl sulfonamide derivatives
06/23/2005US20050137224 2-Cyanopyrrolidinecarboxamide compound
06/23/2005US20050137216 Heterocyclic sodium/proton exchange inhibitors and method
06/23/2005US20050137213 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
06/23/2005US20050137212 Hppars activators
06/23/2005US20050137202 Heterocyclic compounds as antiinflammatory agents and cyclooxygenase inhibitors
06/23/2005US20050137200 Potassium channel modulators; antiarrhythmia agents
06/23/2005US20050137196 Medical devices employing triazine compounds and compositions thereof
06/23/2005US20050137193 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; (2-phenylsulfonamidophenyl)-pyridinyl-methanones; N-[4-chloro-2(pyridine4-carbonyl)-phenyl]4-morpholin-4-yl-benzenesulfonamide
06/23/2005US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels
06/23/2005US20050137187 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
06/23/2005US20050137161 Methods and compositions for treating hepatitis C virus
06/23/2005US20050135737 Optical interleaver
06/23/2005DE10353657A1 New quinolonyl- or benzopyranonyl-substituted indole derivatives are 5HT(1A)- and/or 5HT(1D)-agonists useful e.g. as anxiolytic, antidepressant, neuroleptic and/or antihypertensive agents
06/23/2005CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005CA2549272A1 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005CA2548922A1 2- ( (2, 3-dihydroxypropyl) aminomethyl) chromane derivatives for use as beta-3 adrenoreceptor agonists in the treatment of urological and inflammatory disorders
06/23/2005CA2548426A1 Substituted piperazines
06/23/2005CA2547573A1 N-alkyl pyrroles as hmg-coa reductase inhibitors
06/23/2005CA2547410A1 1,2,3-triazole amide derivatives as inhibitors of cytokie production
06/23/2005CA2547391A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
06/22/2005EP1542992A2 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof
06/22/2005EP1542990A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors
06/22/2005EP1542987A1 Piperidine-n-oxide-derivatives
06/22/2005EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor
06/22/2005EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
06/22/2005EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
06/22/2005EP1542685A1 Triazole derivatives as transforming growth factor (tgf) inhibitors
06/22/2005EP1542684A2 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors
06/22/2005EP1542675A1 Compounds useful for the inhibition of aldh
06/22/2005EP1542667A2 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
06/22/2005EP1268466B1 Decahydro-isoquinolines
06/22/2005EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors
06/22/2005EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme
06/22/2005CN1630653A Pyrazolyl-substituted heterocycles and their use as phytosanitary products
06/22/2005CN1630651A Novel gamma secretase inhibitors
06/22/2005CN1630650A Nitrogenous heterocyclic compound and medicine thereof
06/22/2005CN1630645A 5-HT receptor ligands and uses thereof
06/22/2005CN1630644A Pyridine and pyrimidine derivatives
06/22/2005CN1630642A Benzenesulfonamide derivatives
06/22/2005CN1630555A Hydroxylation of beta-dicarbonyls with zirconium catalysts
06/22/2005CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound
06/22/2005CN1629158A Pyran derivative
06/22/2005CN1207288C Retroviral protease inhibiting compounds
06/22/2005CN1207283C 4-aminopiperidine derivatives and their use as medicine
06/21/2005US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues
06/21/2005US6908936 Respiratory syncytial virus
06/21/2005US6908935 Calcium receptor modulating agents
06/21/2005US6908931 1-(2,2-diphenyl-ethyl)-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline- 2-carbaldehyde; for treating sleep disorders
06/21/2005US6908924 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
06/21/2005US6908922 Linear cyclic ureas
06/21/2005US6908921 Quinoxalinone derivatives as bradykinin B1 antagonists
06/21/2005US6908920 Pyrimidine derivatives
06/21/2005US6908919 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
06/21/2005US6908915 Tricyclic compounds and their uses as antiarrhythmic antifibrillatory and defibrillatory agents
06/21/2005CA2309473C New 4-arylpiperidine derivatives for the treatment of pruritus
06/21/2005CA2250372C 6-phenylpyridyl-2-amine derivatives
06/16/2005WO2005054430A2 Hepatitis c virus inhibitors
06/16/2005WO2005054233A1 Benzoyl amino pyridil carboxylic acid derivatives as gluokinase activators
06/16/2005WO2005054229A1 4-[(arylmethyl)aminomethyl]piperidine derivatives, preparation thereof and application of same in therapeutics
06/16/2005WO2005054227A1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics
06/16/2005WO2005054212A2 Electroluminescent device
06/16/2005WO2005054201A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
06/16/2005WO2005054192A1 Cosmetic process for preventing or treating the signs of skin ageing or the orange-peel appearance
06/16/2005WO2005054179A2 Hydroxamic acid esters and pharmaceutical use thereof
06/16/2005WO2005053686A1 Indolinone based protein kinase inhibitors
06/16/2005WO2005053663A2 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure
06/16/2005WO2005053614A2 Advanced indolinone based protein kinase inhibitors
1 ... 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 ... 694